Synergistic HPV Prevention and Cervical Cancer Protection System
Legal Citation
Summary of the Inventive Concept
A comprehensive system integrating copper-based uterine cervical devices with AI, IoT, blockchain, and nanomaterial technologies to provide enhanced protection against HPV and cervical cancer, while promoting healthy behavior and secure data sharing.
Background and Problem Solved
The original patent disclosed a method for reducing the incidence and prevalence of HPV using a copper-based uterine cervical device. However, this method has limitations, such as the need for manual insertion and replacement, and the lack of real-time monitoring and data analysis. The new inventive concept addresses these limitations by introducing synergistic combinations of technologies to create a more powerful and effective system.
Detailed Description of the Inventive Concept
The system comprises a copper-based uterine cervical device, an AI-powered monitoring module, an IoT-enabled wearable device, a blockchain-based platform, and a nanomaterial-based sensor. The AI-powered monitoring module tracks cervical microbiome modifications and adjusts the device's surface area accordingly. The IoT-enabled wearable device tracks and analyzes user behavior, providing personalized recommendations. The blockchain-based platform securely stores and shares cervical cancer prevention data, incentivizing healthy behavior through a reward system. The nanomaterial-based sensor detects early signs of cervical cancer, providing timely interventions. The system's components work synergistically to reduce the incidence and prevalence of HPV and cervical cancer.
Novelty and Inventive Step
The new claims introduce novel synergistic combinations of technologies, including AI, IoT, blockchain, and nanomaterials, which are not obvious from the original patent. The integration of these technologies provides a new, more powerful system for HPV prevention and cervical cancer protection.
Alternative Embodiments and Variations
Alternative embodiments may include varying the surface area of the copper-based uterine cervical device, using different types of sensors or monitoring modules, or integrating additional technologies, such as machine learning algorithms or natural language processing. Variations may also include adapting the system for use in different populations or settings, such as in low-resource areas or for specific age groups.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the healthcare and medical device industries, particularly in the areas of women's health, cancer prevention, and disease management. The system's ability to provide enhanced protection against HPV and cervical cancer, while promoting healthy behavior and secure data sharing, makes it an attractive solution for healthcare providers, insurers, and patients.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K9/0039 |
| A | A61 | A61F6/144 |
| A | A61 | A61K33/34 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device technologies for women's reproductive health, specifically focused on HPV prevention and cervical cancer intervention, involving biomedical engineering, medical device design, and preventative healthcare technologies
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with expertise in reproductive health technologies, advanced materials, sensor technologies, and familiarity with emerging digital health platforms. Possesses advanced degree (MS/PhD), understands interdisciplinary technology integration, and has working knowledge of medical device regulatory frameworks
Obviousness Rationale
A PHOSITA would recognize that integrating digital monitoring technologies with existing medical device designs represents a predictable evolution of cervical health interventions. The copper-based uterine device from the source patent provides a clear technological foundation for adding intelligent monitoring and data tracking capabilities. The proposed variations represent logical extensions of existing medical device innovation strategies, utilizing well-established technological domains like AI, IoT, and blockchain to enhance preventative healthcare solutions.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,675 |
|---|---|
| Title | Method for reducing the incidence and prevalence of human papilloma virus (HPV) and for providing protection against sexually transmitted infections |